作者:A. V. Kamernitskii、A. M. Turuta、Ngo Tfai Mai An
DOI:10.1007/bf00961627
日期:1980.4
[EN] POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS MODULATEURS DE NMDA POSITIFS ET LEURS PROCÉDÉS D'UTILISATION
申请人:[en]SAGE THERAPEUTICS, INC.
公开号:WO2023028278A2
公开(公告)日:2023-03-02
Compounds are provided according to Formulae (A-I), (B-I), (C-I), (D-I), (E-I), (F-I), (G-I), and (H-I) : and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present disclosure are contemplated useful for the prevention and treatment of a variety of CNS-related conditions.